We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Target Volume in Noninvasive Positive Pressure Ventilation (CIBLE)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01748656
First Posted: December 12, 2012
Last Update Posted: March 14, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
ResMed
Information provided by (Responsible Party):
AGIR à Dom
  Purpose
Patients with OHS are efficiently managed with long term home-based nocturnal noninvasive positive pressure ventilation (NIPPV). Several NIPPV devices offer the feature of automatically adjusting pressure support (and/or respiratory back-up rate) on the basis of a pre-determined "ideal tidal volume" or "ideal ventilation". However algorithms used to achieve these ideal targets are different among different commercialized devices and the relative efficacy from an algorithm compared to another remains unknown. The main objective is this study is to compare two commercialized NIPPV that have this option

Condition Intervention
Obesity Hypoventilation Syndrome Device: IVAPS Device: AVAPS

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Comparison of Two Noninvasive Positive Pressure Ventilation Devices Using Target Volume Modes in Obesity Hypoventilation Syndrome (OHS): A Pilot Randomized Crossover Controlled Trial

Further study details as provided by AGIR à Dom:

Primary Outcome Measures:
  • Mean Nocturnal transcutaneous CO2 pressure (Mean nocturnal PtCO2) [ Time Frame: 1 night ]
    transcutaneous CO2 pressure is measured overnight. It is a reliable estimation of arterial PaCO2 to monitor nocturnal ventilation in adults with chronic respiratory failure.


Secondary Outcome Measures:
  • Mean transcutaneous CO2 pressure during REM Sleep [ Time Frame: 1 Night ]
  • Mean nocturnal SpO2 [ Time Frame: 1 night ]
  • Awake arterial PaCO2 after 1 hour of NIPPV withdrawal [ Time Frame: After 1 night ]
  • Micro-arousals/hour of sleep [ Time Frame: 1 night ]
  • Sleep Quality assess by Visual analogic scale (100mm) [ Time Frame: 1 night ]
  • Respiratory residual events detected by NIPPV built-in softwares [ Time Frame: 1 Night ]

Enrollment: 12
Study Start Date: January 2013
Study Completion Date: February 2014
Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: AVAPS
AVAPS mode(BIPAP-A30-PHILIPS-RESPIRONICS)1 night
Device: IVAPS
IVAPS mode (RESMED Stelar 150) during 1 night
Active Comparator: IVAPS
IVAPS mode(STELAR 150-RESMED)1 night
Device: AVAPS
AVAPS mode (PHILIPS-RESPIRONICS-A30) during 1 night

Detailed Description:
RESMED Stellar-150 (IVAPS mode)versus PHILIPS-RESPIRONICS A30 (AVAPS-mode).
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patient with Obesity hypoventilation Syndrome (BMI≥ 30 kg/m2 and diurnal PaCO2 ≥ 45mmHg at diagnosis after exclusion of others causes of hypoventilation)
  • 18 to 75 years old
  • In stable state but treated by nocturnal NIPPV for more than 3 months and adherent to NIPPV (above 4h/night).

Exclusion Criteria:

  • patient treated with additional long term Oxygen therapy
  • Patient previously treated by AVAPS mode or IVAPS mode
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01748656


Locations
France
Sleep Laboratory, Grenoble Univeristy Hospital
Grenoble, France, 38900
Sponsors and Collaborators
AGIR à Dom
ResMed
Investigators
Principal Investigator: Jean Louis Pepin, MD PHD CHU Grenoble France
  More Information

Responsible Party: AGIR à Dom
ClinicalTrials.gov Identifier: NCT01748656     History of Changes
Other Study ID Numbers: 12-AGIR-02
First Submitted: December 11, 2012
First Posted: December 12, 2012
Last Update Posted: March 14, 2014
Last Verified: December 2012

Keywords provided by AGIR à Dom:
Noninvasive ventilation
Obesity Hypoventilation Syndrome

Additional relevant MeSH terms:
Syndrome
Obesity
Hypoventilation
Obesity Hypoventilation Syndrome
Disease
Pathologic Processes
Overnutrition
Nutrition Disorders
Overweight
Body Weight
Signs and Symptoms
Respiratory Insufficiency
Respiration Disorders
Respiratory Tract Diseases
Signs and Symptoms, Respiratory
Sleep Apnea, Obstructive
Sleep Apnea Syndromes
Apnea
Sleep Disorders, Intrinsic
Dyssomnias
Sleep Wake Disorders
Nervous System Diseases